Association between initial symptoms and subsequent hospitalization in outpatients with COVID-19: A cohort study.

Background Most individuals with coronavirus disease 2019 (COVID-19) experience mild symptoms and are managed in the outpatient setting. The aim of this study was to determine whether self-reported symptoms at the time of diagnosis can identify patients at risk of clinical deterioration. Methods This was a retrospective cohort study of 671 outpatients with laboratory-confirmed COVID-19 diagnosed in Toronto between March 1 and October 16, 2020. We examined the association between patients' baseline characteristics and self-reported symptoms at the time of diagnosis and the risk of subsequent hospitalization. Results Of 671 participants, 26 (3.9%) required hospitalization. Individuals aged 65 years or older were more likely to require hospitalization (odds ratio [OR] 5.29, 95% CI 2.19 to 12.77), whereas those without medical comorbidities were unlikely to be hospitalized (OR 0.02, 95% CI 0.00 to 0.17). After adjusting for age and presence of comorbidities, sputum production (adjusted OR [aOR] 5.01, 95% CI 1.97 to 12.75), arthralgias (aOR 4.82, 95% CI 1.85 to 12.53), diarrhea (aOR 4.56, 95% CI 1.82 to 11.42), fever (aOR 3.64, 95% CI 1.50 to 8.82), chills (aOR 3.62, 95% CI 1.54 to 8.50), and fatigue (aOR 2.59, 95% CI 1.04 to 6.47) were associated with subsequent hospitalization. Conclusions Early assessment of symptoms among outpatients with COVID-19 can help identify individuals at risk of clinical deterioration. Additional studies are needed to determine whether more intense follow-up and early intervention among high-risk individuals can alter the clinical trajectory of and outcomes among outpatients with COVID-19.

[1]  S. Mubareka,et al.  Diagnostic accuracy of subjective dyspnoea in detecting hypoxaemia among outpatients with COVID-19: a retrospective cohort study , 2021, BMJ Open.

[2]  M. Killerby,et al.  Symptom Profiles and Progression in Hospitalized and Nonhospitalized Patients with Coronavirus Disease, Colorado, USA, 2020 , 2021, Emerging infectious diseases.

[3]  C. Hoong,et al.  Viral arthralgia a new manifestation of COVID-19 infection? A cohort study of COVID-19-associated musculoskeletal symptoms , 2021, International Journal of Infectious Diseases.

[4]  C. Qin,et al.  Mucus production stimulated by IFN-AhR signaling triggers hypoxia of COVID-19 , 2020, Cell Research.

[5]  D. Raoult,et al.  Asymptomatic hypoxia in COVID-19 is associated with poor outcome , 2020, International Journal of Infectious Diseases.

[6]  J. Obasanya,et al.  Presenting Symptoms and Predictors of Poor Outcomes Among 2,184 Patients with COVID-19 in Lagos State, Nigeria , 2020, International Journal of Infectious Diseases.

[7]  S. Parisi,et al.  Viral arthritis and COVID-19 , 2020, The Lancet Rheumatology.

[8]  F. Bishehsari,et al.  S1358 Gastrointestinal Symptoms Predict the Outcomes of COVID-19 Infection , 2020 .

[9]  C. Fung,et al.  Predicting severe outcomes in Covid-19 related illness using only patient demographics, comorbidities and symptoms , 2020, The American Journal of Emergency Medicine.

[10]  Y. Manabe,et al.  The Clinical Course of COVID-19 in the Outpatient Setting: A Prospective Cohort Study , 2020, medRxiv.

[11]  M. Kattan,et al.  Development and validation of a model for individualized prediction of hospitalization risk in 4,536 patients with COVID-19 , 2020, PloS one.

[12]  Manish M Patel,et al.  Characteristics of Adult Outpatients and Inpatients with COVID-19 — 11 Academic Medical Centers, United States, March–May 2020 , 2020, MMWR. Morbidity and mortality weekly report.

[13]  Chaoqun Han,et al.  Diarrhea and altered inflammatory cytokine pattern in severe coronavirus disease 2019: Impact on disease course and in‐hospital mortality , 2020, Journal of gastroenterology and hepatology.

[14]  David A. Drew,et al.  Symptom clusters in COVID-19: A potential clinical prediction tool from the COVID Symptom Study app , 2020, Science Advances.

[15]  Jin-Min Yuan,et al.  Predictive symptoms and comorbidities for severe COVID-19 and intensive care unit admission: a systematic review and meta-analysis , 2020, International Journal of Public Health.

[16]  Robert Brown,et al.  Silent hypoxia: A harbinger of clinical deterioration in patients with COVID-19 , 2020, The American Journal of Emergency Medicine.

[17]  Leora I. Horwitz,et al.  Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study , 2020, BMJ.

[18]  Fei-Ran Guo Active smoking is associated with severity of coronavirus disease 2019 (COVID-19): An update of a meta-analysis , 2020, Tobacco induced diseases.

[19]  M. Shi,et al.  Enteric involvement in hospitalised patients with COVID-19 outside Wuhan , 2020, The Lancet Gastroenterology & Hepatology.

[20]  Anna Stachel,et al.  Obesity in patients younger than 60 years is a risk factor for Covid-19 hospital admission , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[21]  S. Mubareka,et al.  A virtual care program for outpatients diagnosed with COVID-19: a feasibility study. , 2020, CMAJ open.

[22]  Centers for Disease Control and Prevention CDC COVID-19 Response Team Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) — United States, February 12–March 16, 2020 , 2020, MMWR. Morbidity and mortality weekly report.

[23]  C. Vardavas,et al.  COVID-19 and smoking: A systematic review of the evidence , 2020, Tobacco induced diseases.

[24]  G. Lippi,et al.  Active smoking is not associated with severity of coronavirus disease 2019 (COVID-19) , 2020, European Journal of Internal Medicine.

[25]  G. Remuzzi,et al.  COVID-19 and Italy: what next? , 2020, The Lancet.

[26]  J. Xiang,et al.  Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study , 2020, The Lancet.

[27]  De-Min Han,et al.  Gender Differences in Patients With COVID-19: Focus on Severity and Mortality , 2020, Frontiers in Public Health.

[28]  Zunyou Wu,et al.  Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. , 2020, JAMA.

[29]  G. Foster,et al.  Shorter treatments for hepatitis C: another step forward? , 2015, The Lancet.